LEP and cancer: Leptin, via SOCS-STAT3 transcription activation, activates many downstream signaling pathways, such as MAPK and AKT pathways, resulting in increased angiogenesis, proliferation, decreased cancer cell death, and therapeutic resistance (Cirillo et al., 2008).